Physician

Timothy A. Mixon, M.D.

According to 2025 Medicare claims, Timothy Mixon, M.D. (NPI: 1881654317) practices interventional cardiology in the Killeen-Temple, TX market, with the plurality of this provider's patient population coming from Bell, TX. This provider's primary affiliated billing organization is SCOTT & WHITE CLINIC (NPI: 1093779704; TIN: 742958277) and primary practice location at 76508-0001. Mixon is affiliated with the Baylor Scott & White Quality Alliance (ACO ID: A2542) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Mixon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 304 traditional Medicare patients, billed 732 HCPCS/CPT codes, and received $102,905 in Medicare payments. The top billing code was 93454 (Insertion of tube in coronary artery for diagnosis with review by radiologist). Part D data shows 893 prescription claims across 204 beneficiaries totaling $123,588 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 80 records totaling $14,674. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $63,259 to $123,588. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,119	3,316	$158,402
2016	1,410	2,282	$153,421
2017	813	1,619	$155,951
2018	700	1,352	$137,640
2019	755	1,400	$136,974
2020	559	1,015	$110,721
2021	595	1,197	$137,239
2022	582	1,265	$146,461
2023	476	1,005	$110,013
2024	304	732	$102,905

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	207	1,299	$63,259
2016	213	1,261	$83,513
2017	189	1,115	$62,142
2018	171	834	$47,201
2019	200	972	$83,430
2020	230	1,166	$90,231
2021	289	1,257	$125,476
2022	319	1,633	$177,987
2023	294	1,395	$147,630
2024	204	893	$123,588

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93454	Insertion of tube in coronary artery for diagnosis with review by radiologist	38	38	$136
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	32	32	$130
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	39	42	$102
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	94	107	$71
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	110	117	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	33	2,238	$41,941
Jardiance	Empagliflozin	14	1,260	$20,274
Xarelto	Rivaroxaban	25	1,150	$20,056
Atorvastatin Calcium	Atorvastatin Calcium	119	10,470	$2,251
Metoprolol Succinate	Metoprolol Succinate	78	6,937	$1,427

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	67	$2,307	Edwards Lifesciences Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	13	$12,367	Edwards Lifesciences Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Timothy A. Mixon, M.D.?

Tedicare shows public-source Medicare data for Timothy A. Mixon, M.D. (NPI 1881654317), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Timothy A. Mixon, M.D. have ACO affiliation data?

Timothy A. Mixon, M.D. is shown with ACO affiliation data for Baylor Scott & White Quality Alliance (MSSP, ACO ID A2542) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Timothy A. Mixon, M.D.?

Timothy A. Mixon, M.D. is linked to SCOTT & WHITE CLINIC (billing NPI 1093779704) in the available physician profile data.

Does Timothy A. Mixon, M.D. have Open Payments data?

Timothy A. Mixon, M.D. has 80 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.